HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
K Shinozaki Selected Research
K Shinozaki Research Topics
Disease
10
Dehydration (Water Stress)
06/2001 - 03/2000
7
Neoplasms (Cancer)
06/2018 - 05/2000
3
Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 05/2015
3
Infections
12/2001 - 03/2001
2
Colonic Neoplasms (Colon Cancer)
11/2021 - 01/2016
2
Drug-Related Side Effects and Adverse Reactions
10/2001 - 03/2001
1
Opioid-Induced Constipation
06/2018
1
Adenocarcinoma
10/2015
1
Stomach Neoplasms (Stomach Cancer)
10/2015
1
Neutropenia
05/2015
1
Onychomycosis (Tinea Unguium)
04/2014
1
Colitis
11/2009
1
Pseudomembranous Enterocolitis (Pseudomembranous Colitis)
11/2009
1
Pancreatitis
11/2009
1
Renal Insufficiency (Renal Failure)
11/2009
1
Acute Kidney Injury (Acute Renal Failure)
11/2009
1
Carcinoma (Carcinomatosis)
09/2003
1
Gastroenteritis
07/2002
1
Serous Cystadenoma
01/2002
1
Chronic Pancreatitis
01/2002
1
Bruton type agammaglobulinemia
12/2001
1
Nephrotic Syndrome (Syndrome, Nephrotic)
09/2001
1
Convalescence
08/2001
1
Necrosis
06/2001
1
Esophageal Neoplasms (Esophageal Cancer)
04/2001
1
Shock
02/2001
1
Pathologic Constriction (Stenosis)
01/2001
1
Insulin Resistance
09/2000
1
Neuroblastoma
03/2000
Drug/Important Bio-Agent (IBA)
5
Elements
IBA
02/2001 - 03/2000
4
Abscisic Acid
IBA
10/2000 - 06/2000
3
Oxaliplatin (Eloxatin)
FDA Link
Generic
11/2021 - 01/2016
3
Carrier Proteins (Binding Protein)
IBA
07/2000 - 03/2000
2
Irinotecan (Camptosar)
FDA Link
Generic
01/2019 - 05/2015
2
Mucins
IBA
01/2002 - 05/2000
1
Cetuximab (Erbitux)
FDA Link
01/2019
1
regorafenib
IBA
01/2019
1
Narcotic Antagonists (Opioid Antagonists)
IBA
06/2018
1
naldemedine
IBA
06/2018
1
Bevacizumab (Avastin)
FDA Link
01/2016
1
S-1 plus cisplatin
IBA
10/2015
1
Hydrocortisone (Cortisol)
FDA Link
Generic
04/2014
1
Itraconazole (Sporanox)
FDA Link
Generic
04/2014
1
Cytochrome P-450 CYP3A
IBA
04/2014
1
Cytochrome P-450 CYP3A Inhibitors
IBA
04/2014
1
Vancomycin
FDA Link
Generic
11/2009
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
08/2003
1
Antineoplastic Agents (Antineoplastics)
IBA
08/2003
1
Capsid Proteins (Capsid Protein)
IBA
07/2002
1
Immunoglobulin G (IgG)
IBA
12/2001
1
Agammaglobulinaemia Tyrosine Kinase
IBA
12/2001
1
Steroids
IBA
09/2001
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
09/2001
1
Signaling Lymphocytic Activation Molecule Associated Protein
IBA
08/2001
1
DNA (Deoxyribonucleic Acid)
IBA
08/2001
1
Immunoglobulins (Immunoglobulin)
IBA
06/2001
1
Phosphatidic Acids (Phosphatidic Acid)
IBA
06/2001
1
Phospholipase D
IBA
06/2001
1
Messenger RNA (mRNA)
IBA
06/2001
1
Type C Phospholipases
IBA
02/2001
1
Inositol 1,4,5-Trisphosphate
IBA
02/2001
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
02/2001
1
1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dione
IBA
02/2001
1
Enzymes
IBA
02/2001
1
Neomycin
FDA Link
Generic
02/2001
1
Mannitol (Osmitrol)
FDA Link
Generic
02/2001
1
Phosphatidylinositol 4,5-Diphosphate (Phosphatidylinositol 4,5 Diphosphate)
IBA
02/2001
1
Secretin
FDA Link
01/2001
1
Fructose
IBA
09/2000
1
Triglycerides (Triacylglycerol)
IBA
09/2000
1
Complementary DNA (cDNA)
IBA
06/2000
1
9-cis-epoxy-carotenoid dioxygenase
IBA
06/2000
1
DNA-Binding Proteins (DNA Binding Protein)
IBA
06/2000
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
03/2000
1
Glucuronidase
IBA
03/2000
Therapy/Procedure
4
Therapeutics
05/2015 - 09/2001
2
Catheters
10/2001 - 03/2001
1
Adjuvant Chemotherapy
11/2021
1
Drug Therapy (Chemotherapy)
10/2015
1
Oral Administration
11/2009
1
Hemodiafiltration
11/2009
1
Vascular Access Devices (Arterial Line)
10/2001
1
Fluid Therapy (Oral Rehydration Therapy)
06/2001
1
Esophagectomy
04/2001